AKT1 and neoplasm: Current research indicates that the TRIM protein is expressed differently across different malignant tumors, mainly through the regulation of various mechanisms such as the p53 and AKT signaling pathway, modulating sensitivity to chemotherapy drugs, expressing tumor-related factors, and playing roles in promoting or suppressing cancer [14, 15].